215 related articles for article (PubMed ID: 36166499)
1. Granulocyte Colony-Stimulating Factor Improved Core Symptoms of Autism Spectrum Disorder via Modulating Glutamatergic Receptors in the Prefrontal Cortex and Hippocampus of Rat Brains.
Mishra A; Singla R; Kumar R; Sharma A; Joshi R; Sarma P; Kaur G; Prajapat M; Bhatia A; Medhi B
ACS Chem Neurosci; 2022 Oct; 13(20):2942-2961. PubMed ID: 36166499
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of the standardised extract of Bacopa monnieri (BacoMind) in valproic acid model of autism spectrum disorder in rats.
Abhishek M; Rubal S; Rohit K; Rupa J; Phulen S; Gurjeet K; Raj SA; Manisha P; Alka B; Ramprasad P; Bikash M
J Ethnopharmacol; 2022 Jul; 293():115199. PubMed ID: 35346813
[TBL] [Abstract][Full Text] [Related]
3. Risperidone impedes glutamate excitotoxicity in a valproic acid rat model of autism: Role of ADAR2 in AMPA GluA2 RNA editing.
Habib MZ; Elnahas EM; Aboul-Ela YM; Ebeid MA; Tarek M; Sadek DR; Negm EA; Abdelhakam DA; Aboul-Fotouh S
Eur J Pharmacol; 2023 Sep; 955():175916. PubMed ID: 37460052
[TBL] [Abstract][Full Text] [Related]
4. The neuroprotective effect of Diosgenin in the rat Valproic acid model of autism.
Reza Naghdi M; Ahadi R; Motamed Nezhad A; Sadat Ahmadi Tabatabaei F; Soleimani M; Hajisoltani R
Brain Res; 2024 Sep; 1838():148963. PubMed ID: 38705555
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the ERK1/2 Phosphorylation by Dextromethorphan Protects against Core Autistic Symptoms in VPA Induced Autistic Rats:
Singla R; Mishra A; Joshi R; Kumar R; Sarma P; Sharma AR; Kaur G; Bhatia A; Medhi B
ACS Chem Neurosci; 2021 May; 12(10):1749-1767. PubMed ID: 33913688
[TBL] [Abstract][Full Text] [Related]
6. Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoid-mediated synaptic dysfunction in a valproic acid-induced rat model of Autism.
Wu HF; Lu TY; Chu MC; Chen PS; Lee CW; Lin HC
Neuropharmacology; 2020 Jan; 162():107736. PubMed ID: 31398381
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase inhibitor, ibudilast alleviates core behavioral and biochemical deficits in the prenatal valproic acid exposure model of autism spectrum disorder.
Sandhu A; Rawat K; Gautam V; Sharma A; Kumar A; Saha L
Brain Res; 2023 Sep; 1815():148443. PubMed ID: 37290608
[TBL] [Abstract][Full Text] [Related]
8. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
Mirza R; Sharma B
Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
[TBL] [Abstract][Full Text] [Related]
9. Improvement of autistic-like behaviors in adult rats prenatally exposed to valproic acid through early suppression of NMDA receptor function.
Mohammadi S; Asadi-Shekaari M; Basiri M; Parvan M; Shabani M; Nozari M
Psychopharmacology (Berl); 2020 Jan; 237(1):199-208. PubMed ID: 31595334
[TBL] [Abstract][Full Text] [Related]
10. Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice.
Hara Y; Ago Y; Taruta A; Hasebe S; Kawase H; Tanabe W; Tsukada S; Nakazawa T; Hashimoto H; Matsuda T; Takuma K
Psychopharmacology (Berl); 2017 Nov; 234(21):3217-3228. PubMed ID: 28798977
[TBL] [Abstract][Full Text] [Related]
11. Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder.
Luhach K; Kulkarni GT; Singh VP; Sharma B
J Pharm Pharmacol; 2021 Oct; 73(11):1460-1469. PubMed ID: 34459916
[TBL] [Abstract][Full Text] [Related]
12. Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism.
Kim JW; Seung H; Kim KC; Gonzales ELT; Oh HA; Yang SM; Ko MJ; Han SH; Banerjee S; Shin CY
Neuropharmacology; 2017 Feb; 113(Pt A):71-81. PubMed ID: 27638451
[TBL] [Abstract][Full Text] [Related]
13. Homotaurine ameliorates the core ASD symptomatology in VPA rats through GABAergic signaling: Role of GAD67.
Singla R; Mishra A; Joshi R; Sarma P; Kumar R; Kaur G; Sharma AR; Jain A; Prakash A; Bhatia A; Medhi B
Brain Res Bull; 2022 Nov; 190():122-133. PubMed ID: 36113682
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome Analysis and Epigenetics Regulation in the Hippocampus and the Prefrontal Cortex of VPA-Induced Rat Model.
Chen L; Fu Q; Du Y; Jiang ZY; Cheng Y
Mol Neurobiol; 2024 Jan; 61(1):167-174. PubMed ID: 37592184
[TBL] [Abstract][Full Text] [Related]
15. Prangos ferulacea (L.) ameliorates behavioral alterations, hippocampal oxidative stress markers, and apoptotic deficits in a rat model of autism induced by valproic acid.
Saadat M; Taherian AA; Aldaghi MR; Raise-Abdullahi P; Sameni HR; Vafaei AA
Brain Behav; 2023 Nov; 13(11):e3224. PubMed ID: 37596045
[TBL] [Abstract][Full Text] [Related]
16. Novel potential of metformin on valproic acid-induced autism spectrum disorder in rats: involvement of antioxidant defence system.
Ishola IO; Balogun AO; Adeyemi OO
Fundam Clin Pharmacol; 2020 Dec; 34(6):650-661. PubMed ID: 32415700
[TBL] [Abstract][Full Text] [Related]
17. Novel role of peroxisome proliferator activated receptor-α in valproic acid rat model of autism: Mechanistic study of risperidone and metformin monotherapy versus combination.
Elnahas EM; Abuelezz SA; Mohamad MI; Nabil MM; Abdelraouf SM; Bahaa N; Hassan GAM; Aboul-Fotouh S
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Jun; 116():110522. PubMed ID: 35131336
[TBL] [Abstract][Full Text] [Related]
18. Syringic acid alleviates valproic acid induced autism via activation of p38 mitogen-activated protein kinase: Possible molecular approach.
Mallan S; Singh S
Environ Toxicol; 2023 Oct; 38(10):2400-2415. PubMed ID: 37357844
[TBL] [Abstract][Full Text] [Related]
19. Vitamin A supplementation ameliorates prenatal valproic acid-induced autism-like behaviors in rats.
Liu Z; Wang J; Xu Q; Wu Z; You L; Hong Q; Zhu J; Chi X
Neurotoxicology; 2022 Jul; 91():155-165. PubMed ID: 35594946
[TBL] [Abstract][Full Text] [Related]
20. Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder.
Kumar H; Sharma BM; Sharma B
Neurochem Int; 2015 Dec; 91():34-45. PubMed ID: 26498253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
